WP Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
2,096
+3
| +0.1% | +$1.58K | 0.3% | 51 |
|
|
2025
Q1 | $1.33M | Sell |
2,093
-138
| -6% | -$87.5K | 0.44% | 44 |
|
|
2024
Q4 | $1.59M | Sell |
2,231
-102
| -4% | -$72.7K | 0.53% | 36 |
|
|
2024
Q3 | $2.45M | Sell |
2,333
-278
| -11% | -$292K | 0.9% | 28 |
|
|
2024
Q2 | $2.74M | Sell |
2,611
-165
| -6% | -$173K | 0.88% | 25 |
|
|
2024
Q1 | $2.67M | Sell |
2,776
-40
| -1% | -$38.5K | 0.88% | 25 |
|
|
2023
Q4 | $2.47M | Sell |
2,816
-25
| -0.9% | -$22K | 0.92% | 24 |
|
|
2023
Q3 | $2.34M | Sell |
2,841
-20
| -0.7% | -$16.5K | 0.97% | 24 |
|
|
2023
Q2 | $2.06M | Sell |
2,861
-92
| -3% | -$66.1K | 0.82% | 27 |
|
|
2023
Q1 | $2.43M | Hold |
2,953
| – | – | 1% | 23 |
|
|
2022
Q4 | $2.13M | Sell |
2,953
-53
| -2% | -$38.2K | 0.95% | 27 |
|
|
2022
Q3 | $2.07M | Hold |
3,006
| – | – | 0.94% | 25 |
|
|
2022
Q2 | $1.78M | Sell |
3,006
-49
| -2% | -$29K | 0.77% | 30 |
|
|
2022
Q1 | $2.13M | Sell |
3,055
-110
| -3% | -$76.8K | 0.88% | 26 |
|
|
2021
Q4 | $2M | Hold |
3,165
| – | – | 0.83% | 29 |
|
|
2021
Q3 | $1.92M | Sell |
3,165
-30
| -0.9% | -$18.2K | 0.79% | 26 |
|
|
2021
Q2 | $1.79M | Buy |
3,195
+181
| +6% | +$101K | 0.74% | 26 |
|
|
2021
Q1 | $1.43M | Buy |
+3,014
| New | +$1.43M | 0.62% | 32 |
|